Skip to main content
Clinical Trials/NCT06179732
NCT06179732CompletedPhase 3

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities:A Cluster Randomised Trial

The Mentor Initiative2 sites in 1 country2,400 target enrollmentStarted: June 5, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
2,400
Locations
2
Primary Endpoint
epidemiological outcome: malaria incidence

Study Overview

Brief Summary

The aim of this study is to determine the effectiveness of a new spatial repellent (called Mesh) at repelling multiple disease vectors and, reducing clinical malaria rates in temporary shelters and camp settings. The design of the study will be a two-armed cluster randomised trial.

By conducting the research in challenging camp settings in the north of Nigeria, the MENTOR Initiative aims to determine whether Mesh can be effective in harsh camp conditions where communities are living in conflict area temporary shelters.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Masking Description

Neither the deliverers of the intervention nor the outcome assessors are blinded to the group allocations.

Eligibility Criteria

Ages
6 Years to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Shelters with 1 or more children from 6-10 years old
  • Shelters with an adult/head of the household

Exclusion Criteria

  • Shelters without children from 6-10 years old

Outcomes

Primary Outcomes

epidemiological outcome: malaria incidence

Time Frame: 7 months

Malaria incidence will be estimated as the total number of malaria episodes per person over the course of the trial.

entomological outcome: vector density

Time Frame: 7 months

the relative infestation rate of disease vectors (females of any of Anopheles malaria vectors, Aedes aegypti, or phlebotomine sand flies

Secondary Outcomes

  • feasibility, acceptance and uptake of Mesh(7 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials